Synergetic effects of aqueous extracts of Fuzi (Radix Aconiti Lateralis Preparata) and Tubeimu (Rhizoma Bolbostemmatis) on MDA-MB-231 and SKBR3 cells
OBJECTIVE: To test the synergistic effects of the aqueous extract of Tubeimu (Rhizoma Bolbosternmatis) and Fuzi (Radix Aconiti Lateralis Preparata) on MDA-MB-231 and SKBR3 breast cancer cells.METHODS: A combined index was created for the effects of Tubeimu (Rhizoma Bolbostemmatis) and Fuzi (Radix Ac...
Saved in:
Published in | 中医杂志:英文版 no. 1; pp. 113 - 124 |
---|---|
Main Author | |
Format | Journal Article |
Language | English |
Published |
2016
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | OBJECTIVE: To test the synergistic effects of the aqueous extract of Tubeimu (Rhizoma Bolbosternmatis) and Fuzi (Radix Aconiti Lateralis Preparata) on MDA-MB-231 and SKBR3 breast cancer cells.METHODS: A combined index was created for the effects of Tubeimu (Rhizoma Bolbostemmatis) and Fuzi (Radix Aconiti Lateralis Preparata) extracts. Cell proliferation was performed by trypan blue exclusion and 3-(4,5-dimethylthiazol-2-yl)-5-(3- carboxy- methoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium (MTS) assays. Flow cytometry was used to assess cell cycle distribution and apoptosis. Cell migration was determined by wound-healing and transwell assays. Confocal microscopy was used to detect E-cadherin and actin filaments. RESULTS: The aqueous extract from Tubeimu (Rhizoma Bolbostemmatis)and Fuzi (Radix Aconiti lateralis Preparata) exerted synergetic effects on the growth of MDA-MB-231 cells and G1 phase arrest. When exposed to extracts at concentrations of 62.5 :62.5 and 62.5:31.3 μg/mL, the combination index was 0.83 and 0.74, respectively. Interestingly, 62.5: 31.3 μg/mL of combined drugs enhanced the inhibitory effect of Tubeimu (Rhizoma Bolbostemmatis) on the migration of SKBR3 cells and reduced the stimulative effect of Fuzi (Radix Aconiti Lateralis Preparata) (P 〈 0.01), in which cells showed an increased expression of E-cadherin and reorganization of actin filaments (P 〈 0.001). 62.5:62.5 μg/mL extract also synergistically induced apoptosis of MDA-MB-231 cells (P 〈 0.05 and P 〈 0.001). Acting as the main active ingredients in the extract, tubeimoside I and acetylbenzoylaconine at 10:10μg/ mL and 5:2.5 μg/mL also produced inhibitory effects on the proliferation and migration of cells (P 〈 0.01). CONCLUSION: Tubeimu (Rhizoma Bolbostemmatis) and Fuzi (Radix Aconiti Lateralis Preparata) extracts had synergic effects on MDA-MB-231 and SKBR3 cells. |
---|---|
Bibliography: | OBJECTIVE: To test the synergistic effects of the aqueous extract of Tubeimu (Rhizoma Bolbosternmatis) and Fuzi (Radix Aconiti Lateralis Preparata) on MDA-MB-231 and SKBR3 breast cancer cells.METHODS: A combined index was created for the effects of Tubeimu (Rhizoma Bolbostemmatis) and Fuzi (Radix Aconiti Lateralis Preparata) extracts. Cell proliferation was performed by trypan blue exclusion and 3-(4,5-dimethylthiazol-2-yl)-5-(3- carboxy- methoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium (MTS) assays. Flow cytometry was used to assess cell cycle distribution and apoptosis. Cell migration was determined by wound-healing and transwell assays. Confocal microscopy was used to detect E-cadherin and actin filaments. RESULTS: The aqueous extract from Tubeimu (Rhizoma Bolbostemmatis)and Fuzi (Radix Aconiti lateralis Preparata) exerted synergetic effects on the growth of MDA-MB-231 cells and G1 phase arrest. When exposed to extracts at concentrations of 62.5 :62.5 and 62.5:31.3 μg/mL, the combination index was 0.83 and 0.74, respectively. Interestingly, 62.5: 31.3 μg/mL of combined drugs enhanced the inhibitory effect of Tubeimu (Rhizoma Bolbostemmatis) on the migration of SKBR3 cells and reduced the stimulative effect of Fuzi (Radix Aconiti Lateralis Preparata) (P 〈 0.01), in which cells showed an increased expression of E-cadherin and reorganization of actin filaments (P 〈 0.001). 62.5:62.5 μg/mL extract also synergistically induced apoptosis of MDA-MB-231 cells (P 〈 0.05 and P 〈 0.001). Acting as the main active ingredients in the extract, tubeimoside I and acetylbenzoylaconine at 10:10μg/ mL and 5:2.5 μg/mL also produced inhibitory effects on the proliferation and migration of cells (P 〈 0.01). CONCLUSION: Tubeimu (Rhizoma Bolbostemmatis) and Fuzi (Radix Aconiti Lateralis Preparata) extracts had synergic effects on MDA-MB-231 and SKBR3 cells. Radix Aconiti Lateralis Preparata; Bolbostemma Paniculatum; Drugs, Chinese Herbal;Breast neoplasms; MDA-MB-231; SKBR3 11-2167/R |
ISSN: | 0255-2922 |